Zobrazeno 1 - 6
of 6
pro vyhledávání: '"William Regine"'
Autor:
Timothy Meiller, Claire Fraser, Silvia Grant-Beurmann, Mike Humphrys, Luke Tallon, Lisa Sadewicz, Mary Ann Jabra-Rizk, Areej Alfaifi, Anmar Kensara, Jason Molitoris, Matthew Witek, William Mendes, William Regine, Phuoc Tran, Robert Miller, Ahmed Sultan
Publikováno v:
Journal of Cancer and Allied Specialties, Vol 10, Iss 1 (2023)
Introduction: Due to the radiation-sparing effects on salivary gland acini, changes in the composition of the oral microbiome may be a driver for improved outcomes in patients receiving proton radiation with potentially worse outcomes in patients exp
Externí odkaz:
https://doaj.org/article/a072446f03604be8a146ed54884060b3
Autor:
Jacob Eckstein, MD, J. Isabelle Choi, MD, Alicia Lozano, MS, Nitin Ohri, MD, Robert Press, MD, Shaakir Hasan, DO, Rafi Kabarriti, MD, John Chang, MD, James Urbanic, MD, Michael Durci, MD, Nasiruddin Mohammed, MD, Craig Stevens, MD, PhD, Henry Tsai, MD, Smith Apisarnthanarax, MD, William Regine, MD, Carlos Vargas, MD, Romaine Nichols, Jr, MD, Joseph Herman, MD, Charles B. Simone, II, MD, Arpit Chhabra, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 5, Pp 101250- (2023)
Purpose: Compared with photon-based techniques, proton beam radiation therapy (PBT) may improve the therapeutic ratio of radiation therapy (RT) for locally advanced pancreatic cancer (LAPC), but available data have been limited to single-institutiona
Externí odkaz:
https://doaj.org/article/5974ac5f635146098c27e46c38db1a87
Autor:
Cedric X, Yu, Xinyu, Shao, Jin, Zhang, William, Regine, Mike, Zheng, Ying S, Yu, Jianchun, Deng, Zhengcheng, Duan
Publikováno v:
Medical physics. 40(5)
This paper introduces a new external beam radiotherapy device named GammaPod that is dedicated for stereotactic radiotherapy of breast cancer.The design goal of the GammaPod as a dedicated system for treating breast cancer is the ability to deliver a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ecc68c47caf8bd631f4172245697114
https://pubmed.ncbi.nlm.nih.gov/23635251
https://pubmed.ncbi.nlm.nih.gov/23635251
Autor:
Towne Penny, Jim Ranger-Moore, Mitch Raponi, Tone Ikdahl, Volker Heinemann, Lindsey Rolfe, Steffen Ormanns, Adam P. Dicker, Bill Richardson, Jeff Isaacson, William Regine, Roland Andersson, Elizabeth Poplin, Andrew M. Allen, Kathryn Winter, June Clements, Stefan Boeck, Thomas Kirchner
Publikováno v:
Annals of Oncology. 23:iv59-iv60
Introduction Human equilibrative nucleoside transporter 1 (hENT1) is the primary membrane channel through which gemcitabine (Gem) enters pancreatic tumor cells, and patients whose tumors have low expression of hENT1 may derive little benefit from Gem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa4d0077fd32b56d9efea5bf840e79fa
https://doi.org/10.1016/s0923-7534(20)30306-9
https://doi.org/10.1016/s0923-7534(20)30306-9
Autor:
Meraj, Mohiuddin, Damodaran, Chendil, Swatee, Dey, Rachael A, Alcock, William, Regine, Mohammed, Mohiuddin, Mansoor M, Ahmed
Publikováno v:
Anticancer research. 22(2A)
While p53 protein plays an important role in the regulation of radiosensitivity and chemosensitivity in many tumors, the role of p53 in the combined management of tumors that harbor mutations in the p53 gene have not been fully defined. This study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::04d95984c0c95e18d986c6f884e0b8fb
https://pubmed.ncbi.nlm.nih.gov/12014658
https://pubmed.ncbi.nlm.nih.gov/12014658
Autor:
Stephen M, Hahn, Eric J, Bernhard, William, Regine, Mohammed, Mohiuddin, Daniel G, Haller, James P, Stevenson, Debbie, Smith, Barnali, Pramanik, Joel, Tepper, Thomas F, DeLaney, Krystina D, Kiel, Briggs, Morrison, Paul, Deutsch, Ruth J, Muschel, W Gillies, McKenna
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(5)
Preclinical data have demonstrated that farnesyltransferaseinhibitors (FTIs) are radiation sensitizers in selected cell lines. The objective of this Phase I trial was to determine the maximally tolerated dose of the FTI L-778,123 in combination with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20d76143b9f27e2e237c27133b2a58eb
https://pubmed.ncbi.nlm.nih.gov/12006520
https://pubmed.ncbi.nlm.nih.gov/12006520